InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,650.00
(
0.05%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.59
(
0.00%
)
Bitcoin
61,126.27
(
0.54%
)
Post# of 14668
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

zigzagman

Send PM Follow Ignore
Followers 646
Posts 144549
Boards Moderated 1
Alias Born 05/19/2007

zigzagman

Re: pivotpoint1 post# 109

Thursday, 03/10/2016 2:53:22 PM

Thursday, March 10, 2016 2:53:22 PM

Post# of 14668
ETBI has a Patent for Lorazopem!

“We look forward to progressing with this key pharmaceutical development with these patent publications leading the way” says Anna Gluskin, EastGate’s CEO. “Lorazepam oral spray, based on our proprietary delivery technology, can be groundbreaking in the anti-seizure market where a fast and effective treatment can be applied by any patient or caregiver resulting in a positive therapeutic impact” continues Gluskin.


http://www.eastgatebiotech.com/investors/press-releases/eastgate-patent-lorazopem

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up